This is a preview of subscription content, log in via an institution to check access.
References
O’Mahony C. Genital warts: current and future management options. Am J Clin Dermatol 2005: 6(4): 239–43
British national formulary. No. 51. London: The Pharmaceutical Press, 2006 Mar
O’Mahony C, Law C, Gollnick HPM, et al. New patient-applied therapy for anogenital warts is rated favourably by patients. Int J STD AIDS 2001; 12: 565–70
von Krogh G, Lacey CJ, Gross G, et al. European guideline for the management of anogenital warts. Int J STD AIDS 2001; 12Suppl. 3: 40–7
Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National Guidelines for the management of anogenital warts. Sex Transm Infect 1999; 75Suppl. 1: 71–5
Centres for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51: 53–7
O’Mahony C. Management of imiquimod induced erythema. HPV Today 2004; 4: 15
O’Mahony C. Difficult wart cases: use of imiquimod cream 5%. Int J STD AIDS 2001; 12: 400–3
Wolters Kluwer Health, Inc. Facts & comparisons 4.0 [online]. Available from URL: http://online.factsandcomparisons.com [Accessed 2006 Mar 20]
Rights and permissions
About this article
Cite this article
Genital warts can often be effectively treated at home with podophyllotoxin or imiquimod. Drugs Ther. Perspect 22, 17–18 (2006). https://doi.org/10.2165/00042310-200622070-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200622070-00005